Your cart is currently empty!
Blog
Tirofiban Hcl
Description
This page contains brief details about the drug tirofiban hcl, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Tirofiban hydrochloride (HCl) was initially approved by the U.S. Food and Drug Administration (FDA) on June 3, 1998.
Mechanism of Action of Tirofiban Hcl
Tirofiban hydrochloride (HCl)works by inhibiting the glycoprotein IIb/IIIa receptor on the surface of platelets. This receptor plays a crucial role in platelet aggregation and clot formation. By blocking this receptor, tirofiban helps prevent the formation of blood clots.
Uses of Tirofiban Hcl
Tirofiban hydrochloride (HCl) is an antiplatelet medication with multiple clinical applications. Its primary uses include managing acute coronary syndromes (ACS), encompassing unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI), by reducing the risk of coronary artery clot formation. During percutaneous coronary interventions (PCI) like angioplasty and stent placement, it prevents platelet aggregation and clot formation at the intervention site. Additionally, it is occasionally considered for managing thrombocytopenia, investigated for ischemic stroke cases, used in some coronary artery bypass grafting (CABG) procedures to minimize graft occlusion risk, and employed adjunctively in high-risk patients prone to clot formation.
Tirofiban Hcl Dosage available
Tirofiban hydrochloride (HCl) is typically administered intravenously (IV), giving it directly into a vein. It is usually administered in a healthcare setting, such as a hospital, where medical professionals can closely monitor the patient.
Afatinib Dimaleate
Description
This page contains brief details about the drug afatinib dimaleate, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Afatinib Dimaleate is an anticancer medicine was approved by the US Food and Drug Administration (FDA) on July 12, 2013, to treat patients with non-small cell lung cancer (NSCLC) whose tumors have certain (non-resistant) abnormal epidermal growth factor receptor (EGFR) genes and patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy.
Mechanism of Action of Afatinib Dimaleate
It functions by inhibiting the ErbB family of proteins, which includes EGFR (also known as the epidermal growth factor receptor, or ErbB1, ErbB2, ErbB3, and ErbB4) and HER2. Changes in the genes that create these proteins can have an impact on how cancer cells multiply and disseminate. Through the inhibition of these proteins and its activities, this medication can prevent the growth and proliferation of cancer cells and can help to slow or stop the progression of cancer.
Uses of Afatinib Dimaleate
Afatinib dimaleate is used to treat certain types of cancer, including non-small cell lung cancer with specific EGFR mutations.
Afatinib Dimaleate Dosage available
Afatinib dimaleate is an oral medication that is usually taken once a day, at approximately the same time each day, before food. If you have already eaten, wait at least 3 hours before taking this medicine.
It should be taken as prescribed by a doctor. These tablets should be swallowed whole with a glass of water. They should not be crushed, chewed, or opened, as this can affect how the medication is absorbed and decrease its effectiveness. Take the missed dose as soon as you recall if your next planned dose is more than eight hours away. You should not take a double dose to make up for the second dose.
Tacrolimus
Description
This page contains brief details about the drug tacrolimus, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Tacrolimus is an immunosuppressant that was approved for its medical use on 8th April 1994.
Mechanism of Action of Tacrolimus
Tacrolimus is an immunosuppressant that prevents organ rejection in organ transplantation. It is classified as an immunosuppressant belonging to the category of Calcineurin inhibitors. Tacrolimus works by binding to a protein called FKBP-12 and forms a complex called tacrolimus-FKBP, which inhibits the action of calcineurin phosphatase. This, in turn, inhibits the formation of T cells and suppresses the immune response. Tacrolimus is often prescribed along with other immunosuppressants like azathioprine and mycophenolate mofetil.
Uses of Tacrolimus
Tacrolimus has been developed to prevent organ rejection in adult and pediatric patients receiving an allogeneic transplant of the liver, kidney, heart, or lung.
Tacrolimus Dosage available Tacrolimus is available in the form of capsules, injections, oral suspensions, and ointments. Tacrolimus Capsule is available in doses 0.5mg, 1mg, and 5mg. your healthcare provider will administer Tacrolimus Injection (5mg/ml) if you are unable to tolerate an oral capsule or suspension. Your healthcare provider will prescribe the accurate dose based on the organ transplanted, body weight, and health condition. Patients diagnosed with cystic fibrosis might require higher doses.
Adenosine
Description
This page contains brief details about the drug adenosine, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Adenosine was initially approved by the U.S. Food and Drug Administration (FDA) for medical use in the United States on October 30, 1989. It has been available as a prescription medication since then for the management of specific cardiac conditions, particularly supraventricular tachycardia (SVT).
Mechanism of Action of Adenosine
Adenosine has a therapeutic effect on the cardiovascular system, primarily used for the diagnosis and treatment of supraventricular tachycardia (SVT). As an antiarrhythmic agent, it works by temporarily slowing down the heart rate and interrupting abnormal electrical pathways in the heart, restoring normal sinus rhythm. This rapid action helps terminate episodes of SVT and relieves individuals experiencing rapid heart rhythms. Adenosine’s ability to restore normal heart rhythm makes it an effective tool for diagnosing and managing certain cardiac arrhythmias, contributing to the overall management of cardiovascular health.
Uses of Adenosine
Adenosine is used to diagnose and treat supraventricular tachycardia (SVT) and as a stress agent in certain cardiac imaging tests.
Adenosine Dosage available
Adenosine is administered intravenously (vein injection) under medical supervision. Your healthcare professional will determine the specific dosage and administration guidelines based on your condition and needs.
Brentuximab Vedotin
Description
This page contains brief details about the drug brentuximab vedotin, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
The Brentuximab vedotin is medically approved for the treatment of Hodgkin lymphoma, cutaneous T-cell lymphoma and systemic Anaplastic Large Cell Lymphoma.
Mechanism of Action of Brentuximab Vedotin
Brentuximab vedotin consists of an antibody targeting CD30, a protein found on the surface of cancer cells, and a chemotherapy drug attached to the antibody. The antibody delivers the chemotherapy directly to the cancer cells, minimizing damage to healthy cells.
Uses of Brentuximab Vedotin
Brentuximab vedotin is used to treat various cancers, including classical Hodgkin lymphoma (both newly diagnosed and relapsed), systemic anaplastic large cell lymphoma, primary cutaneous anaplastic large cell lymphoma, cutaneous T-cell lymphoma, and CD30-expressing mycosis fungoides, all in combination with other therapies.
Brentuximab Vedotin Dosage available
Brentuximab vedotin can be administered only as an intravenous injection into a vein by your physician in a hospital setting. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.
Darbepoetin Alfa
Description
This page contains brief details about the drug darbepoetin alfa, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Darbepoetin Alfa is a medication indicated to treat anaemia. It was approved for its medical use on 17th September 2001.
Mechanism of Action of Darbepoetin Alfa
Darbepoetin Alfa Injection is a biological agent that works to treat anaemia. It is produced by gene-technology in Chinese hamster ovary cells and acts in the same way as the hormone erythropoietin synthesized by the kidneys. It induces the bone marrow to produce more red blood cells and eventually reduces anaemia.
Uses of Darbepoetin Alfa
Darbepoetin Alfa Injection has been developed to treat anaemia in children and adults with chronic kidney disease (renal failure) and those receiving chemotherapy for non-bone marrow cancers.
Darbepoetin Alfa Dosage available
Darbepoetin alfa is available in injection form in the doses 25mcg, 40mcg, 60mcg, 100mcg, 200mcg, 500mcg. Your physician will calculate the accurate dose after monitoring your blood counts.
For chronic renal failure, the initial recommended dose is 0.75mcg/kg bodyweight every two weeks or 0.45mcg/kg bodyweight weekly once. For patients not on dialysis the ideal dose is 1.5mcg/kg bodyweight once monthly.
For patients undergoing chemotherapy treatment, the recommended dose is 500mcg once every three weeks or 2.25mcg once weekly.
Tocilizumab
Description
This page contains brief details about the drug tocilizumab, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
The U.S. FDA approved tocilizumab on 08/01/2010. This medicine belongs to a group of monoclonal antibodies (a protein made from specific immune cells).
Mechanism of Action of Tocilizumab
The medication inhibits the function of a particular protein known as interleukin-6, which plays a role in the body’s inflammatory responses. By blocking this protein, it can help decrease inflammation within your body.
Uses of Tocilizumab
This is used in conditions such as moderate to severe active rheumatoid arthritis (RA) and who have inadequate response with other rheumatoid drugs, giant cell arteritis (disease in arteries), children with systemic juvenile idiopathic arthritis (sJIA), polyarticular juvenile idiopathic arthritis (pJIA).
Tocilizumab Dosage available
The medicine will be administered to you by a healthcare professional in a hospital setting. It is usually administered in the vein (intravenous). Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.